• Health Policy Expert Peter Bach, MD, Goes to Biotech Company

    2 monthes ago - By Medscape

    A fierce critic of drug costs, Peter Bach, MD, has left academia for a small biotech company working on liquid biopsy for lung cancer.
    Medscape Medical News
    Read more ...